Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

13,267 total articles

TCG Crossover GP II Reduces Surrozen Stake with $6.9M Share Sale

TCG Crossover GP II Reduces Surrozen Stake with $6.9M Share Sale

TCG Crossover GP II, LLC, acting as a 10% owner and director of Surrozen Inc. (NASDAQ: SRZN), completed a significant divestiture by selling 325,000 shares of common stock on July 22, 2026. The total transaction value reached $6,906,250, with each share priced at $21.25. In compliance with Section 16(b) of the Securities Exchange Act of 1934, the r…

Mink Brook Asset Management Increases DLHC Stake Near 52-Week Low

Mink Brook Asset Management Increases DLHC Stake Near 52-Week Low

Mink Brook Asset Management LLC has executed additional open market purchases of DLH Holdings Corp. (NASDAQ: DLHC) stock, bringing its total beneficial ownership to over 2.1 million shares. The acquisitions occurred over two days in late July 2026, as the stock traded near its 52-week low. Concurrently, DLH Holdings announced significant executive …

Horizon Kinetics Director Acquires Additional RENN Fund Equity Stake

Horizon Kinetics Director Acquires Additional RENN Fund Equity Stake

Horizon Kinetics Asset Management LLC, acting as a director and significant 10% shareholder of RENN Fund, Inc., executed a recent equity acquisition. The firm purchased 756 shares of common stock on July 23, 2026, at a price of $3.06 per share, bringing the total transaction value to $2,313. This purchase increases Horizon Kinetics' direct holdings…

3M Executive Executes Stock Sale Following Option Exercise

3M Executive Executes Stock Sale Following Option Exercise

3M Company (NYSE:MMM) Executive Vice President John Patrick Banovetz executed a stock sale on July 23, 2026, following the exercise of non-qualified stock options. The transaction involved the sale of 7,880 shares at $170.44 per share, generating approximately $1.34 million. This activity occurs as 3M reports strong second-quarter earnings that exc…

Rani Therapeutics Director Mir A Imran Acquires $24,839 in Stock Amid Clinical and Corporate Developments

Rani Therapeutics Director Mir A Imran Acquires $24,839 in Stock Amid Clinical and Corporate Developments

Mir A. Imran, a director and significant shareholder in Rani Therapeutics Holdings, Inc. (NASDAQ:RANI), recently executed a purchase of 36,000 shares of the company's Class A Common Stock. This transaction, valued at $24,839, occurred against a backdrop of recent corporate developments, including the announcement of positive initial data from a Pha…